<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Spontaneous <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> (SCE) are frequent in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effect of SCE on the rates of cognitive and functional decline in AD and VaD </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: One hundred thirty-two patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> (74 AD, National Institute of Neurological and <z:e sem="disease" ids="C0009460" disease_type="Mental or Behavioral Dysfunction" abbrv="">Communicative Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>-<z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e> and Related Disorders Association [NINCDS/ADRDA] criteria; 58 VaD, National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>-Association Internationale pour la Recherche et l'Enseignement en Neurosciences [NINDS/AIREN] criteria) underwent 1-hour transcranial Doppler for detection of SCE (mean [SD] age 75.5 (7.4) years; 46% female) </plain></SENT>
<SENT sid="3" pm="."><plain>Neuropsychological tests (Mini-Mental State Examination [MMSE], <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e> Assessment Scale-Cognitive subscale [ADAS-Cog], and Neuropsychiatric Inventory [NPI]) and assessment of activities of daily living (Interview for Deterioration in Daily Living Activities in <z:hpo ids='HP_0000726'>Dementia</z:hpo> [IDDD]) were performed initially and 6 months later </plain></SENT>
<SENT sid="4" pm="."><plain>SCE positive (SCE+ve, n = 47) and SCE negative (SCE-ve, n = 85) patients were compared using repeated measures analyses of variance (ANOVAs) adjusted for age, gender, and <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: SCE+ve patients with <z:hpo ids='HP_0000726'>dementia</z:hpo>, both AD and VaD, suffered a more rapid decline in cognitive functioning over 6 months (ADAS-cog, mean increase 7.1 for SCE+ve compared with 3.3 for SCE-ve, p = .006) and activities of daily living (IDDD, mean increase 24.4 for SCE+ve compared with 10.8 for SCE-ve, p = .014) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Asymptomatic SCE are associated with an accelerated cognitive and functional decline in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>SCE may be a potentially treatable cause of disease progression in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>